ANRO
Alto Neuroscience, Inc.
NYSE · Healthcare · Biotechnology · US
$22.45
−4.35%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 94.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.02x
- Price / sales
- —
- Price / cash flow
- -12.90x
Enterprise value
- Enterprise value
- $644.3M
- EV / sales
- —
- EV / EBITDA
- -7.93x
- EV / EBIT
- 14.49x
- Market cap
- $881.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026